S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Why Lucid Spiked Nearly 100% In One Day
The Next Big Crisis Is Here (Ad)
Ride These Railroad Stocks for Growth and Income
Is Buying an Aged Corporation a Good Idea?
Is This The End of Capitalism? (Ad)
MarketBeat Week in Review – 1/23- 1/27
Visa, L3Harris rise; Intel, Eastman Chemical fall
The Next Big Crisis Is Here (Ad)
How major US stock indexes fared Friday 1/27/2023
Closing prices for crude oil, gold and other commodities
S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Why Lucid Spiked Nearly 100% In One Day
The Next Big Crisis Is Here (Ad)
Ride These Railroad Stocks for Growth and Income
Is Buying an Aged Corporation a Good Idea?
Is This The End of Capitalism? (Ad)
MarketBeat Week in Review – 1/23- 1/27
Visa, L3Harris rise; Intel, Eastman Chemical fall
The Next Big Crisis Is Here (Ad)
How major US stock indexes fared Friday 1/27/2023
Closing prices for crude oil, gold and other commodities
S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Why Lucid Spiked Nearly 100% In One Day
The Next Big Crisis Is Here (Ad)
Ride These Railroad Stocks for Growth and Income
Is Buying an Aged Corporation a Good Idea?
Is This The End of Capitalism? (Ad)
MarketBeat Week in Review – 1/23- 1/27
Visa, L3Harris rise; Intel, Eastman Chemical fall
The Next Big Crisis Is Here (Ad)
How major US stock indexes fared Friday 1/27/2023
Closing prices for crude oil, gold and other commodities
S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Why Lucid Spiked Nearly 100% In One Day
The Next Big Crisis Is Here (Ad)
Ride These Railroad Stocks for Growth and Income
Is Buying an Aged Corporation a Good Idea?
Is This The End of Capitalism? (Ad)
MarketBeat Week in Review – 1/23- 1/27
Visa, L3Harris rise; Intel, Eastman Chemical fall
The Next Big Crisis Is Here (Ad)
How major US stock indexes fared Friday 1/27/2023
Closing prices for crude oil, gold and other commodities
NASDAQ:CGEN

Compugen - CGEN News Today

$0.87
0.00 (0.00%)
(As of 01/27/2023 12:00 AM ET)
Add
Compare
Today's Range
$0.85
$0.89
50-Day Range
$0.65
$1.20
52-Week Range
$0.51
$3.68
Volume
439,341 shs
Average Volume
603,001 shs
Market Capitalization
$75.22 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$5.40
Get Compugen News Delivered to You Automatically

Sign up to receive the latest news and ratings for CGEN and its competitors with MarketBeat's FREE daily newsletter.



CGEN Media Mentions By Week

CGEN Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

CGEN
News Sentiment

0.36

0.70

Average
Medical
News Sentiment

CGEN News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

CGEN Articles
This Week

4

2

CGEN Articles
Average Week

SourceHeadline
MarketBeat logoCompugen Ltd. (NASDAQ:CGEN) Receives $6.67 Average Price Target from Analysts
americanbankingnews.com - January 25 at 3:48 AM
MarketBeat logoBrokerages Set Compugen Ltd. (NASDAQ:CGEN) Target Price at $6.67
americanbankingnews.com - January 25 at 3:48 AM
finance.yahoo.com logoCompugen to Participate in the JMP Securities C-Suite Series- TIGIT Landscape Overview
finance.yahoo.com - January 23 at 7:27 AM
finance.yahoo.com logoWhy Shares of Compugen Rose on Thursday
finance.yahoo.com - January 6 at 8:05 AM
finance.yahoo.com logoCompugen's COM701 (anti-PVRIG) in Dual and Triple Combination Demonstrates Preliminary Durable Anti-Tumor Activity and Immune Activation in Patients with Platinum Resistant Ovarian Cancer
finance.yahoo.com - December 14 at 2:09 AM
finance.yahoo.com logoCompugen's COM701 (anti-PVRIG) in Dual and Triple Combination Demonstrates Preliminary Anti-Tumor Activity and Immune Activation in Platinum Resistant Ovarian Cancer Patients
finance.yahoo.com - December 1 at 7:49 PM
finance.yahoo.com logoWhy Shares of Compugen Rose 16.5% on Wednesday
finance.yahoo.com - November 30 at 5:32 PM
msn.com logoWhy Shares of Compugen Jumped 17.86% on Thursday
msn.com - November 19 at 6:24 PM
finance.yahoo.com logoCompugen to Receive Milestone Payment Triggered by AstraZeneca's Phase 2 Initiation of PD-1/TIGIT Bispecific
finance.yahoo.com - November 16 at 4:07 PM
finance.yahoo.com logoWhy Compugen Stock Crumbled Today
finance.yahoo.com - November 15 at 5:51 AM
finance.yahoo.com logoCompugen Reports Third Quarter 2022 Results
finance.yahoo.com - November 14 at 12:04 PM
markets.businessinsider.com logoSVB Securities Sticks to Its Buy Rating for Compugen (CGEN)
markets.businessinsider.com - November 11 at 5:41 AM
finance.yahoo.com logoCompugen to Participate in the Stifel Healthcare Conference
finance.yahoo.com - November 8 at 11:17 AM
finance.yahoo.com logoCompugen's COM701 (anti-PVRIG) Induces Potent Immune Activation in MSS-CRC Patients
finance.yahoo.com - November 7 at 11:45 AM
finance.yahoo.com logoCompugen's COM701 (anti-PVRIG) in Combination with Nivolumab Demonstrates Preliminary Anti-Tumor Activity and Potent Immune Activation in Metastatic MSS-CRC Patients
finance.yahoo.com - November 7 at 11:45 AM
finance.yahoo.com logoCompugen Announces Receipt of Nasdaq Delisting Notice
finance.yahoo.com - November 2 at 7:34 PM
finance.yahoo.com logoCompugen to Present New Clinical Data at ESMO-IO
finance.yahoo.com - October 26 at 8:38 AM
reuters.com logoCGEN.TA - Compugen Ltd. | Stock Price & Latest News | Reuters
reuters.com - October 22 at 10:44 PM
businesswire.com logoComputational Biology Global Market Report 2022: Featuring Accelrys, Certara, Chemical Computing Group, Compugen & Entelos - ResearchAndMarkets.com - Business Wire
businesswire.com - October 18 at 11:46 PM
reuters.com logoCGEN.A - Compugen Ltd. (USA) | Stock Price & Latest News | Reuters
reuters.com - October 15 at 2:07 PM
globenewswire.com logoHead and Neck Cancer Clinical Trial Pipeline: Analysis of 130+ Key Companies Working in the Domain | DelveInsight - GlobeNewswire
globenewswire.com - October 10 at 1:31 PM
finance.yahoo.com logoCompugen to Present New Clinical and Research Data in Two Oral Presentations at SITC 2022
finance.yahoo.com - October 6 at 7:51 AM
uk.finance.yahoo.com logoComputational Biology Global Market Report 2022 - Yahoo Finance UK
uk.finance.yahoo.com - September 30 at 3:13 PM
finance.yahoo.com logoCompugen Letter to Shareholders - Yahoo Finance
finance.yahoo.com - September 23 at 10:36 AM
finance.yahoo.com logoCompugen Letter to Shareholders
finance.yahoo.com - September 22 at 9:38 AM
morningstar.com logoCompugen Ltd CGEN Stock Quote
morningstar.com - September 15 at 8:34 PM
nasdaq.com logoCompugen Names Alberto Sessa CFO, Effective Nov. 1
nasdaq.com - September 12 at 11:59 AM
finance.yahoo.com logoCompugen Announces Appointment of Alberto Sessa as Chief Financial Officer
finance.yahoo.com - September 12 at 11:59 AM
finance.yahoo.com logoShareholders in Compugen (NASDAQ:CGEN) are in the red if they invested a year ago
finance.yahoo.com - September 1 at 5:22 PM
investorplace.com logoThese 2 'Perfect' Indicators Say the Bear Market Is Over - InvestorPlace
investorplace.com - August 26 at 1:22 AM
ca.finance.yahoo.com logoFILAMENT HEALTH APPOINTS NEW MEMBERS TO BOARD OF DIRECTORS AND ADVISORY COUNCIL - Yahoo Canada Finance
ca.finance.yahoo.com - August 25 at 12:19 AM
finance.yahoo.com logoCompugen Expands anti-PVRIG COM701 Patent Portfolio with New Composition of Matter and Use Patent in Japan
finance.yahoo.com - August 24 at 9:38 AM
benzinga.com logoAnalyst Ratings for Compugen - Benzinga
benzinga.com - August 23 at 11:37 PM
markets.businessinsider.com logoTruist Securities Maintains Buy Rating for Compugen: Here's What You Need To Know
markets.businessinsider.com - August 23 at 6:37 PM
markets.businessinsider.com logoAnalyst Ratings for Compugen
markets.businessinsider.com - August 23 at 6:37 PM
reuters.com logoCGEN.OQ - Compugen Ltd. (USA) | Stock Price & Latest News | Reuters
reuters.com - August 22 at 6:19 PM
finance.yahoo.com logoChemomab Adds Highly Experienced Executives Further Strengthening Its R&D and Clinical Capabilities - Yahoo Finance
finance.yahoo.com - August 12 at 10:49 AM
msn.com logoJMP Securities Maintains Market Outperform Rating for Compugen: Here's What You Need To Know
msn.com - August 8 at 11:07 PM
benzinga.com logoThis Analyst Lowers Price Target On Lyft; Also Check Out Some Other Major PT Changes - Benzinga
benzinga.com - August 8 at 5:45 PM
finance.yahoo.com logoCompugen Expands anti-PVRIG COM701 Intellectual Property Portfolio
finance.yahoo.com - August 8 at 5:44 PM
seekingalpha.com logoCompugen Ltd. (CGEN) CEO Anat Cohen-Dayag on Q2 2022 Results - Earnings Call Transcript
seekingalpha.com - August 5 at 10:21 AM
seekingalpha.com logoCompugen GAAP EPS of -$0.11 beats by $0.01 (NASDAQ:CGEN) - Seeking Alpha
seekingalpha.com - August 5 at 5:21 AM
investing.com logoCompugen Tops Q2 EPS by 1c By Investing.com - Investing.com
investing.com - August 4 at 2:20 PM
in.investing.com logoCompugen Tops Q2 EPS by 1c By Investing.com - Investing.com India
in.investing.com - August 4 at 9:19 AM
finance.yahoo.com logoCompugen Reports Second Quarter 2022 Results
finance.yahoo.com - August 4 at 9:19 AM
benzinga.com logoEarnings Preview For Compugen - Benzinga
benzinga.com - August 3 at 6:18 PM
seekingalpha.com logoCompugen Q2 2022 Earnings Preview (NASDAQ:CGEN) - Seeking Alpha
seekingalpha.com - August 3 at 1:17 PM
finance.yahoo.com logoCompugen to Release Second Quarter Results on Thursday, August 4, 2022
finance.yahoo.com - July 29 at 1:15 AM
nasdaq.com logoOne Chart Proves That Tech Stocks Are Due for a Huge Breakout! - Nasdaq
nasdaq.com - July 28 at 8:49 AM
streetinsider.com logovTv Therapeutics (VTVT) Appoints Paul Sekhri as President and CEO - StreetInsider.com
streetinsider.com - July 27 at 12:47 PM
Get Compugen News Delivered to You Automatically

Sign up to receive the latest news and ratings for CGEN and its competitors with MarketBeat's FREE daily newsletter.

This page (NASDAQ:CGEN) was last updated on 1/28/2023 by MarketBeat.com Staff